Cargando…

OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)

Detalles Bibliográficos
Autores principales:	Todeschini, A., Contaldo, A., Macaluso, F.S., Facciotti, F., Castiglione, F., Nardone, O.M., Spagnuolo, R., Doldo, P., Riguccio, G., Conforti, F.S., Viganò, C., Ascolani, M., Bodini, G., Milla, M., Scardino, G., Vernero, M., Desideri, F., Mannino, M., Rizzo, G., Di Leo, A., Orlando, A., Principi, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022
Materias:	Oral Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065948/ http://dx.doi.org/10.1016/S1590-8658(22)00278-X

Ejemplares similares

PC.01.4 REDUCED IMMUNE RESPONSE INDUCED BY TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IG-IBD STUDY
por: Macaluso, F.S., et al.
Publicado: (2022)

OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY
por: Macaluso, F.S., et al.
Publicado: (2023)

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

OC.06.8 THE EMERGING ROLE OF TELEMEDICINE IN GASTROENTEROLOGY DURING THE COVID-19 PANDEMIC: A STUDY ON ITS FEASIBILITY AND PATIENTS’ TRUST
por: Costantino, A., et al.
Publicado: (2021)

OC.06.9 ASSESSMENT OF SARCOPENIA AND NUTRITIONAL STATUS IN A COHORT OF PATIENTS WITH CROHN’S DISEASE
por: Nardone, O.M., et al.
Publicado: (2021)

P03-021 - Characterization of BM-MSC from osteopetrotic mice
por: Schena, F, et al.
Publicado: (2013)

PW02-021 - SAA1 is the strongest predictor of AA in TRAPS
por: Obici, L, et al.
Publicado: (2013)

O021 Indigenous Sleep Health Survey
por: Yeo, S, et al.
Publicado: (2023)

P-021: THE LIVING WELL WITH SICKLE CELL MOBILE APPLICATION
por: A., MATTHEWS, et al.
Publicado: (2022)

Large $N_{c}$, chiral approach to $M_{\eta}'$ at finite temperature
por: Escribano, R., et al.
Publicado: (2000)

P01-021 – Macrophage migration inhibitory factory in FMF
por: Sari, I, et al.
Publicado: (2013)

AF.49 DETERMINANTS OF COVID-19 VACCINE HESITANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): RESULTS OF A NATIONAL SURVEY OF THE ITALIAN IBD PATIENTS’ ASSOCIATION (AMICI ONLUS)
por: Costantino, A., et al.
Publicado: (2021)

Complete Genome Sequence of Human Coronavirus OC43 Isolated from Mexico
por: Taboada, B. T., et al.
Publicado: (2016)

UCG report on the LHCb VELO upgrade TDR (CERN-LHCC-2013-021)
por: Barker, G, et al.
Publicado: (2014)

OC.06.3 POST-COVID-19 IRRITABLE BOWEL SYNDROME
por: Marasco, G., et al.
Publicado: (2023)

Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes
por: Lobato, G.R., et al.
Publicado: (2017)

LBODP021 Multifactorial Hypercalcemia
por: Ramachandran, Aishwarya, et al.
Publicado: (2022)

Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists
por: Sellers, William F.S., et al.
Publicado: (2022)

OC.05.6 HELICOBACTER PYLORI AND SARS-COV-2: A DANGEROUS PATHOGENETIC CORRELATION?
por: Termite, F., et al.
Publicado: (2023)

Viral contaminants of molluscan shellfish: detection and characterisation
por: Bosch, A., et al.
Publicado: (2009)

OC.02.2 REDUCED EXPRESSION OF SARS-COV-2 INFECTION-RELATED GENES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Pisani, L.F., et al.
Publicado: (2022)

OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY
por: Ferretti, F., et al.
Publicado: (2021)

OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
por: Guarino, M., et al.
Publicado: (2022)

Small Bowel Metastatic Melanoma: An Emblematic “Coal-Black” Appearance at Videocapsule Endoscopy
por: Todeschini, Alessia, et al.
Publicado: (2021)

OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS
por: Di Grazia, A., et al.
Publicado: (2021)

OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER
por: Germani, G., et al.
Publicado: (2021)

Frailty index as a clinical measure of biological age in psychiatry
por: Bersani, F.S.
Publicado: (2021)

AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE
por: Macaluso, F.S., et al.
Publicado: (2021)

The implementation of the muFast algorithm in the new PESA framework 021
por: Di Mattia, A, et al.
Publicado: (2003)

The role of pioglitazone in antioxidant, anti-inflammatory, and insulin sensitivity in a high fat-carbohydrate diet-induced rat model of insulin resistance
por: Al-Muzafar, H.M., et al.
Publicado: (2021)

Effect of the hydroalcoholic extract and juice of Prunus divaricata fruit on blood glucose and serum lipids of normal and streptozotocin-induced diabetic rats
por: Minaiyan, M., et al.
Publicado: (2014)

Adaptive optimisation of a generalised phase contrast beam shaping system
por: Kenny, F., et al.
Publicado: (2015)

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies
por: Shen, X, et al.
Publicado: (2009)

PC.01.3 SEVERE ACTIVITY OF INFLAMMATORY BOWEL DISEASE IS A RISK FACTOR FOR SEVERE COVID-19: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)
por: Macaluso, F.S., et al.
Publicado: (2021)

Structural and functional analysis of the S proteins of two human coronavirus OC43 strains adapted to growth in different cells
por: Künkel, F., et al.
Publicado: (1996)

OC.10.2 A SERUM METABOLOMICS ANALYSIS TO UNDERSTAND THE INTERPLAY BETWEEN BIOLOGICAL THERAPIES IN IBD PATIENTS AND SUSCEPTIBILITY TO SARS-COV-2 INFECTION
por: Pisani, L.F., et al.
Publicado: (2022)

Application of penalty clause contract no. 161'021
por: Kamber, I
Publicado: (1978)

AB021. Doctor-patient sexual communication
por: Low, Wah-Yun
Publicado: (2015)

THU021 Mysterious Resolution Of Cushing’s Disease
por: Whiteman, Daniel R, et al.
Publicado: (2023)

OC-0534 Image review for COVID-19 on CBCT vs MIP’s
por: Clough, A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bih5dtbfvu0nigtnc0el6gp7nf